Literature DB >> 33867739

Screening for Human Parvovirus B19 Infection in Egyptian Family Replacement Blood Donors.

Rabab Hasanain Ahmed Hasanain1, Rania M Saleh2, Fadia M Attia2, Hanaa H Gomaa1.   

Abstract

Up till now, screening for human parvovirus B19 is not routine in national Egyptian blood bank strategy. Blood samples were collected from 500 healthy blood donors within the age range from 18 to 45 years old attending the blood bank of Suez Canal University Hospital, Ismailia, Egypt. Sera were separated and stored at - 20 °C. Serum samples were screened for anti-human parvovirus B19 IgM and IgG antibodies and B19 genome using ELISA and real-time PCR respectively. Frequency of B19 IgM and B19 IgG antibodies was 6.20%, and 80.20% respectively, and the prevalence of B19 genome was 3.00%. There is a high frequency of human parvovirus B19 among Egyptian blood donors; therefore, serological screening for B19 is warranted. © Indian Society of Hematology and Blood Transfusion 2020.

Entities:  

Keywords:  Blood transfusion; ELISA; Human parvovirus B19; Real-time PCR

Year:  2020        PMID: 33867739      PMCID: PMC8012424          DOI: 10.1007/s12288-020-01356-y

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  27 in total

1.  Role of integrin cross-regulation in parvovirus B19 targeting.

Authors:  Kirsten A Weigel-Kelley; Mervin C Yoder; Linyuan Chen; Arun Srivastava
Journal:  Hum Gene Ther       Date:  2006-09       Impact factor: 5.695

2.  Screening of blood donors for human parvovirus B19 and characterization of the results.

Authors:  C Wakamatsu; F Takakura; E Kojima; Y Kiriyama; N Goto; K Matsumoto; M Oyama; H Sato; K Okochi; Y Maeda
Journal:  Vox Sang       Date:  1999       Impact factor: 2.144

3.  Seroprevalence of human parvovirus B19 in healthy blood donors.

Authors:  Satish Kumar; R M Gupta; Sourav Sen; R S Sarkar; J Philip; Atul Kotwal; S H Sumathi
Journal:  Med J Armed Forces India       Date:  2013-02-23

4.  Human parvovirus B19 induces cell cycle arrest at G(2) phase with accumulation of mitotic cyclins.

Authors:  E Morita; K Tada; H Chisaka; H Asao; H Sato; N Yaegashi; K Sugamura
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

5.  Transmission of parvovirus B19 by coagulation factor concentrates exposed to 100 degrees C heat after lyophilization.

Authors:  E Santagostino; P M Mannucci; A Gringeri; A Azzi; M Morfini; R Musso; R Santoro; M Schiavoni
Journal:  Transfusion       Date:  1997-05       Impact factor: 3.157

6.  Immediate and long term outcome of human parvovirus B19 infection in pregnancy.

Authors:  E Miller; C K Fairley; B J Cohen; C Seng
Journal:  Br J Obstet Gynaecol       Date:  1998-02

7.  The seroprevalence of Parvovirus B19 among kidney transplant recipients: a single-center study.

Authors:  Zakieh Rostamzadeh Khameneh; Nariman Sepehrvand; Vahid Sohrabi; Nazafarin Ghasemzadeh
Journal:  Saudi J Kidney Dis Transpl       Date:  2014-01

8.  Possible transmission of parvovirus B19 from intravenous immune globulin.

Authors:  D D Erdman; B C Anderson; T J Török; T H Finkel; L J Anderson
Journal:  J Med Virol       Date:  1997-11       Impact factor: 2.327

Review 9.  Human parvovirus B19.

Authors:  Erik D Heegaard; Kevin E Brown
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

10.  Human parvovirus B19 infection in blood donors.

Authors:  M Tsujimura; K Matsushita; H Shiraki; H Sato; K Okochi; Y Maeda
Journal:  Vox Sang       Date:  1995       Impact factor: 2.144

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.